Key Insights

Highlights

Treatment Research

2 treatments under study, led by Fulguration

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT03289260Phase 3Unknown

Adjuvant Anal Imiquimod Therapy in Anal HPV-lesions: AdAM-trial

Showing all 1 trials

Research Network

Common Treatments

  • Fulguration1
  • Imiquimod1

Active Sponsors

  • Medical University Innsbruck1

Top Investigators

Related Conditions

  • Anogenital Human Papillomavirus Infection1

Activity Timeline